glp 1 agonists alzheimer's Glucagon like peptide-1 (GLP-1) likes disease GLP-1 mimetics and cognition -

Balancing weight and muscle loss in GLP1 receptor agonist therapy

Clinical Significance If approved, orforglipron would be the first oral medication specifically approved for chronic weight management that activates the GLP-1 receptor without requiring injection, absorption enhancers, or dietary restrictions

And every guests journey is different

Also promising research to show an increase in GLP-1 production

103 The insulin/insulin-like growth factor (IGF) pathway promotes NSCs proliferation, differentiation, and survival

Krishnan A, Patel RA, Hadi YB et al (2023) Clinical characteristics and outcomes of COVID-19 in patients with autoimmune hepatitis: a population-based matched cohort study